title: Clinical Trial Transparency Is Up for Grabs: The FDA and Congress Are Expanding Public Access to Data.
abstract: Years of complaints about poor access to information on "compassionate use" of experimental drugs and a lack of transparency in clinical trials are driving reform efforts by the National Library of Medicine, the Food and Drug Administration, and Congress.
authors.forename: Stephen
authors.initials: S
authors.lastname: Barlas